Genextra S.p.A., 10% Owner at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 750,000 shares at $105.07 ($78.8M) on 2018-11-29, disclosed to the SEC on 2018-12-03.
Open-market sale of $78.8M ICPT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| ICPT | BUY | 2018-04-09 | $25.0M | — | Filing → |
| ICPT | SELL | 2014-04-11 | $111.0M | — | Filing → |
| ICPT | SELL | 2013-10-23 | $7.8M | — | Filing → |